The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 May 2018 07:00

RNS Number : 3366O
Tarsus Group PLC
17 May 2018
 

17 May 2018

Tarsus Group plc

("Tarsus" or "the Group")

Trading Update

Tarsus Group plc (LSE: TRS), the international business-to-business media group, is today providing a trading update on its current financial year to date.

Trading since the publication of the Group's Annual Results on 28 February 2018 has been in line with the Board's expectations and forward bookings continue to be ahead of our targeted growth range. As previously guided, trading for 2018 is heavily second half weighted with revenues predominantly dollar denominated.

In the US, as expected, the Connect business has traded strongly and the Medical portfolio has continued to grow. In China, the Spring Hometex event was a record edition and trading in Dubai and Mexico has been positive. The trading pattern in Turkey is similar to last year with a weak first half but more positive forward bookings for the larger shows in the second half.

Douglas Emslie, Tarsus Group Managing Director, said:

"We are encouraged by our forward bookings for the year.

"The next phase of our Quickening the Pace strategy, launched in January this year, is focused on increasing the scale of our individual events as well as driving the momentum of the overall portfolio through replication of our leading brands.

"The outlook for the global exhibition industry continues to be positive and with a deepening presence in the US and China - the two largest individual markets - we are well placed to continue to deliver encouraging growth in the years ahead."

The Group plans to announce its Interim Results for the six months ended 30 June 2018 on 26 July 2018.

 

For further information:

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director

+44 (0) 20 8846 2700

Dan O'Brien, Group Finance Director

 

 

Neville Harris, Investor Relations

+44 (0)7909 976044 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUWUAUPRGQQ
Date   Source Headline
12th Jan 20187:00 amRNSTrading Update & launch of next phase of strategy
29th Dec 201710:03 amRNSTotal Voting Rights
13th Dec 20173:22 pmRNSScrip Dividend Circular (the "Circular")
5th Dec 201711:45 amRNSHolding(s) in Company
30th Nov 201710:33 amRNSTotal Voting Rights and Capital
21st Nov 20177:00 amRNSCapital Markets Seminar and Trading Update
14th Nov 20177:00 amRNSSite visit to Dubai Airshow
9th Nov 201710:41 amRNSBlock Listing Six Monthly Return
2nd Nov 20177:00 amRNSChange of Advisers
12th Oct 20177:00 amRNSTrading Statement
26th Sep 20177:00 amRNSAnalyst and Investor Site Visit
22nd Sep 20173:55 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSExpansion of Mexican Joint Venture
6th Sep 201711:38 amRNSBlock Listing Six Monthly Return
31st Aug 20179:31 amRNSTotal Voting Rights
29th Aug 20173:31 pmRNSDirector/PDMR Shareholding
16th Aug 20174:07 pmRNSHalf-year Report
2nd Aug 20171:38 pmRNSDirector/PDMR Shareholding
31st Jul 20172:42 pmRNSTotal Voting Rights
27th Jul 20175:05 pmRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSHalf-year Report
11th Jul 201712:42 pmRNSApplication for Admission
30th Jun 20174:09 pmRNSTotal Voting Rights
21st Jun 201712:13 pmRNSResult of AGM
5th Jun 201711:24 amRNSScrip Dividend Circular
31st May 201710:09 amRNSTotal Voting Rights
19th May 20171:42 pmRNSNotice of AGM
18th May 201712:05 pmRNSHolding(s) in Company
17th May 20177:00 amRNSTrading Update
9th May 20172:45 pmRNSBlock Listing Six Monthly Return
28th Apr 201711:05 amRNSTotal Voting Rights
4th Apr 20175:17 pmRNSHolding(s) in Company
4th Apr 20175:16 pmRNSDirector/PDMR Shareholding
31st Mar 201710:37 amRNSTotal Voting Rights
30th Mar 20176:10 pmRNSDirector/PDMR Shareholding
17th Mar 20172:01 pmRNS2016 Annual Report
16th Mar 20172:29 pmRNSDirector/PDMR Shareholding
15th Mar 20178:41 amRNSHolding(s) in Company
6th Mar 20175:45 pmRNSDirector/PDMR Shareholding
6th Mar 20175:44 pmRNSDirector/PDMR Shareholding
1st Mar 20174:04 pmRNSApplication for Block Listing
1st Mar 20177:00 amRNSFinal Results
8th Feb 201712:19 pmRNSDirector Declaration
1st Feb 201712:02 pmRNSTotal Voting Rights
25th Jan 20177:00 amRNSCompletion of acquisition
17th Jan 201711:14 amRNSApplication for Admission
10th Jan 20177:00 amRNSYear-end Trading Update
30th Dec 20169:03 amRNSTotal Voting Rights
22nd Dec 20167:12 amRNSAcquisition of Hometex
14th Dec 20163:26 pmRNSScript Dividend Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.